13F HOLDINGS REPORT
MPM ASSET MANAGEMENT LLC
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0000950123-25-008430
Total Value
$43.3M
Positions
5
Other Managers
0
Confidential Omitted
No
Holdings (5)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Entrada Therapeutics, Inc. | TRDA | 4,381,062 | $29.4M | 67.92% |
| 2 | Dyne Therapeutics, Inc. | DYN | 682,376 | $6.5M | 14.99% |
| 3 | Werewolf Therapeutics, Inc. | HOWL | 4,309,860 | $4.7M | 10.84% |
| 4 | Repare Therapeutics, Inc. | 760273102 | 1,121,318 | $1.6M | 3.60% |
| 5 | Adaptimmune Therapeutics plc | ADTI | 4,809,677 | $1.2M | 2.66% |